Edinburgh scientists use engineered bacteria to turn everyday plastic waste into essential medicine for Parkinson’s disease.
Imagine a world where the plastic bottle you toss into recycling could one day help heal your brain. Scientists at the University of Edinburgh are bringing that vision to life. Their groundbreaking research shows that discarded PET bottles, the kind we see in drinks and food packaging, can be transformed into L-DOPA, a frontline medication for treating the symptoms of Parkinson’s disease [1].
The magic happens with specially engineered E coli bacteria. These tiny biological factories can digest the plastic and, through a series of carefully designed chemical reactions, turn it into L-DOPA. What used to sit in landfills or drift in oceans can now help improve human lives.
“This feels like just the beginning,” said Professor Stephen Wallace, who led the study. “If we can create medicines for neurological disease from a waste plastic bottle, it’s exciting to imagine what else this technology could achieve.”
Wallace notes that while plastic is typically viewed as an environmental threat, he identifies it as a significant opportunity. He explains that plastic waste represents an extensive, underutilized carbon source. By converting that carbon into pharmaceuticals, the research redefines the material’s value, suggesting that, rather than being mere refuse, waste can serve as a vital resource for medical advancement.
The project is funded by UK Research and Innovation and the Industrial Biotechnology Innovation Centre (IBioIC) and forms part of a broader effort to reimagine waste in creative, useful ways.
Dr Liz Fletcher, the deputy chief executive at IBioIC, stated that converting plastic bottles into a Parkinson’s drug represents more than just an innovative recycling concept. She explained that the initiative serves as a method of redesigning processes to align with nature rather than oppose it, ultimately providing concrete advantages.
Traditionally, pharmaceuticals rely on “virgin” fossil fuels and intensive petrochemical synthesis – essentially making medicine from oil. This new approach replaces that carbon-heavy cycle with a bio-upcycling process that’s more sustainable and potentially more cost-effective. By swapping oil-based production for waste-based drugs, plastic that might otherwise be incinerated, dumped, or polluting oceans is now feeding the creation of life-saving medicine.
The technique also hints at a broader vision, one in which bio-engineered systems could produce not just medicine but also cosmetics, flavorings, fragrances and industrial chemicals – all while minimizing environmental impact.
The team has successfully demonstrated the process at a laboratory scale. The next step is industrialization. Optimizing efficiency, scaling production, and assessing environmental and economic impact.
“This research is a great example of how biology can be engineered to tackle some of society’s most pressing challenges,” said Professor Charlotte Deane, executive chair of UKRI EPSRC. “By converting discarded plastic into a treatment for Parkinson’s disease, the team shows how carbon that would otherwise be lost can become high-value products that improve lives.”
Longevity meets sustainability. Just as biotech research often seeks to extend life by repurposing existing drugs for new diseases, this breakthrough suggests we can extend the life of our planet by repurposing our waste. By treating plastic not as a pollutant to be hidden, but as a molecular library to be tapped, we create a circular healthcare system where the cure for tomorrow’s ailments might literally be found in yesterday’s trash.
By upcycling plastic to treat neurological disorders, we are not just extending lives; we are rethinking how our industries impact the world we age in. As populations grow older and the climate crisis intensifies, solutions like this show that the future of medicine is deeply intertwined with the future of the planet.
Wallace and his team emphasize that their work demonstrates how waste can be reimagined as a resource for human health by using engineered biology to convert plastic into essential medicine. For the longevity community, it’s a reminder that life extension can also be about innovating responsibly, sustainably and creatively.
Main image shows Professor Stephen Wallace harvesting engineered bacteria for analysis (credit: Edinburgh Innovations).
[1] https://www.ed.ac.uk/news/waste-plastic-turned-into-parkinsons-drug
